IVC Filter Problems Increasing, Possibly Due to Aging and Fracturing Risk: Study
The findings of a new study suggest increasing reports of IVC filter problems may be due to the devices aging and fracturing.
The findings of a new study suggest increasing reports of IVC filter problems may be due to the devices aging and fracturing.
A new study warns that people of color are less likely to get advanced, potentially life-saving treatment for pulmonary embolism.
A new study raises doubts about whether Xeljanz and similar drugs increase the risk of blood clots.
A Xeljanz lawsuit claims Pfizer misled the public about the safety of the rheumatoid arthritis drug, leading to a man suffering a life-threatening blood clot.
Users of the blood thinner Xarelto had higher risks of recurrent venous thromboembolism and higher risks of bleeding events than those taking Eliquis, according to the findings of a new…
The FDA has delayed an expanded approval for the drug Jakafi, potentially due to concerns over heart and cancer risks linked to Pfizer's Xeljanz, a similar drug.
Nearly 32,000 stents use to prevent blockages in the veins are being recalled due to the risk of migration and patient injury.
Growing concerns have led to Health Canada announcing a Xeljanz safety review, to determine whether more warnings or actions are needed following studies suggesting the ulcerative colitis drug could increase…
New Xeljanz research links the drug to cancer risks, but has not yet led to a warning for users as to which types of cancer they may face.
The FDA may be delaying approval for the drug Rinvoq to be used as a psoriatic arthritis drug due to its close ties to Xeljanz, which has been linked to…